Intec pharma ltd. (NTEC)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18
CASH FLOWS FROM OPERATING ACTIVITIES:
NET LOSS

-3,870

-6,556

-20,378

-10,009

-10,656

-12,603

-9,178

-11,033

-10,729

Adjustments required to reconcile net loss to net cash used in operating activities:
Depreciation

306

211

212

213

218

220

223

210

206

Exchange differences on cash and cash equivalents

135

-2

88

-27

8

1,357

-160

-328

-40

Change in right of use asset

126

444

172

188

163

-

-

-

-

Change in lease liabilities

152

333

137

145

98

-

-

-

-

Gains on marketable securities

2

-

-

-

-

-53

13

-81

-73

Share-based compensation

442

473

787

1,018

943

775

851

878

723

Changes in operating assets and liabilities:
Decrease in prepaid expenses and other receivables

1,045

-

-

-

340

-

-

-

-

Increase in prepaid expenses and other receivables

-

-

-

-

-

-

-

404

98

Increase in deferred tax assets

-

-504

75

79

69

-

-

-

-

Increase (decrease) in accounts payable and accruals

-3,225

-

-

-1,230

1,813

-

-

996

-390

Increase in other liabilities

48

50

82

87

76

-

-

-

-

Net cash used in operating activities

-5,147

-5,127

-6,191

-10,465

-7,262

-8,127

-11,094

-9,600

-10,255

CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property and equipment

3

130

640

141

10

2,035

19

591

2,022

Investment in other assets

-

550

880

229

1,206

-

-

-

-

Proceeds from disposal of marketable securities, net

772

0

0

0

576

336

-39

-45

46

Net cash (used in) provided by investing activities

769

-680

-1,520

-370

-640

-4,181

-812

-2,332

-1,976

CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of ordinary shares, net of issuance costs

421

-

-

-

-

-

-

-

-

Proceeds from issuance of ordinary shares and warrants, net of issuance costs

5,692

-

-

-

-

-

-

-

-

Proceeds from exercise of options

-

14

0

107

161

-

-

-

-

Net cash provided by financing activities

6,113

131

1,969

107

161

-

-

-

-

INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS

1,735

-

-5,742

-10,728

-7,741

-

-11,906

23,098

-12,231

EXCHANGE DIFFERENCES ON CASH AND CASH EQUIVALENTS

-135

2

-88

27

-8

-1,357

160

328

40

SUPPLEMENTAL DISCLOSURES OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Liability with respect to property and equipment

-

-

-379

40

462

-

-

-

-

Liability with respect to other assets (see note 4a)

-

-

-565

466

648

-

-

-

-

Receivables with respect to exercise of options

-

-

-

-

96

-

-

-

-

SUPPLEMENTARY DISCLOSURE OF CASH FLOW INFORMATION -
Interest received

9

12

52

135

128

212

313

92

117